• 1
    Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359361. MEDLINE
  • 2
    Alter HJ. To C or not to C: these are questions. Blood 1995; 85:16811695. MEDLINE
  • 3
    Doherty PC, Allan W, Eichelberger M. Roles of ab and gd T cell subsets in viral immunity. Annu Rev Immunol 1992; 10:123151. MEDLINE
  • 4
    Kagi D, Lederman B, Burki K, Zinkernagel RM, Hengartner H. Molecular mechanism of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 1996; 14:207. MEDLINE
  • 5
    Koziel MJ, Dudley D, Wong J, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992; 149:33393344. MEDLINE
  • 6
    Battegay M, Fikes J, Di Biscieglie AM, Wentworth PA, Sette A, Celis E, Ching WH, et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus encoded peptides binding to HLA-A2.1 molecule. J Virol 1995; 69:24622470. MEDLINE
  • 7
    Cherny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabbscheid B, Fowler P, et al. Cytotoxic T lymphocyte response to hepatitis C virus derived peptides containing the HLA-A2.1 binding motif. J Clin Invest 1995; 95:521530. MEDLINE
  • 8
    Shirai M, Arichi T, Nishioka M, Nomura T, Icheda K, Kauanishi K, Engelhard VH, et al. CTL Responses of HLA-A2.1-transgenic mice specific for hepatits C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol 1995; 154:27332742. MEDLINE
  • 9
    Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo QL, Houghton M, et al. HLA class I restricted cytotoxic T lymphocytes specific for hepatitis C virus: identification of multiple epitopes and characterization of patterns of cytokines release. J Clin Invest 1995; 96:23112315. MEDLINE
  • 10
    Rehermann B, Chang KM, McHutchinson M, Kokka R, Houghton M, Rice CM, Chisari FV. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996; 70:70927102. MEDLINE
  • 11
    Rehermann B, Chang KM, McHutchinson M, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood CTL response in patients with chronic HCV infection. J Clin Invest 1996; 98:14321440. MEDLINE
  • 12
    Nelson DR, Marousis CG, Davis GL Rice MR, Wong J, Houghton M, Lau JYN. The role of hepatitis C virus–specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997; 158:14731481. MEDLINE
  • 13
    Wong DKH, Dudley DD, Afdhal NH, Dienstag J, Rice CM, Wang L, Houghton M, et al. Liver derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol 1998; 160:14791488. MEDLINE
  • 14
    Nelson DR, Marousis CG, Ohno T, Davis GL, Lau JY. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C. Hepatology 1998; 28:225230. MEDLINE
  • 15
    Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, Chisari FV, Sette A. Identification of HLA-A3 and B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J Immunol 1999; 162:11561164. MEDLINE
  • 16
    Lechner F, Wong DKH, Dunbar PR, Chapman R, Chung RT, Dohenwend P, Robbins G, et al. Analysis of successful immune responses in persons infected with hepatitis C virus J Exp Med 2000; 191:14991512.
  • 17
    Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A, Miller JL, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000; 6:578582. MEDLINE
  • 18
    Tokushige K, Wakita T, Pachuk C, Moradpour Weiner DB, Zurawski VRJ, Wands JR. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 1996; 24:1420. MEDLINE
  • 19
    Inchauspe' G, Major ME, Nakano I, Vitvitski L, Trepo C. DNA vaccination for the induction of immune responses against hepatitis C virus proteins. Vaccine 1997; 15:853856. MEDLINE
  • 20
    Bruna-Romero O, Lasart J, Wilkinson G, Grace K, Clarke B, Borras-Cuesta F, Prieto J. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus. Hepatology 1997; 25:470477. MEDLINE
  • 21
    Encke J, Putlitz J, Geissler M, Wands JR. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J Immunol 1998; 161:49174923. MEDLINE
  • 22
    Forns X, Emerson SU, Tobin GJ, Mushahwar IK, Purcell RH, Bulk J. DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface. Vaccine 1999; 17:19922002. MEDLINE
  • 23
    Lee AY, Manning WC, Arian CL, Polakos NK, Barajas JL, Ulmer JB, Houghton M, et al. Priming of hepatitis C virus-specific cytotoxic T lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA. Hepatology 2000;31:13271333 MEDLINE
  • 24
    Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, et al. Efficient generation of recombinant adenoviruses using adenovirus NA-terminal protein complex and a cosmid bearing the full-length genome. Proc Natl Acad Sci U S A 1996; 93:13201324. MEDLINE
  • 25
    Makimura M, Miyake S, Akino N, Takamori K, Matsuura Y, Miyamura T, Saito I. Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus. Vaccine 1996(1):2836.
  • 26
    Hiasa Y, Horiike N, Akbar SM, Saito I, Miyamura T, Matsuura Y, Onji M. Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes. Biochem Biophys Res Commun 1998; 249(1):9095. MEDLINE
  • 27
    Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S, et al. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res 1995; 23:38163821. MEDLINE
  • 28
    Ralston R, Thudium K, Berger K, Kuo C, Gervase B, Hall J, Selby M, et al. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol 1993; 151:4189.
  • 29
    Penna A, Chisari FV, Bertoletti A, Missale G, Fowler P, Giuberti T, Fiaccadori F, et al. Cytotoxic T lymphocytes recognize an HLA-A2 restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991; 174:15651570. MEDLINE
  • 30
    Moradpour, D, Wakita T, Tokushige K, Carlson RI, Krawczynski K, Wands JR. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein. J Med Virol 1996; 48:234241. MEDLINE
  • 31
    Mondelli MU, Cerino A, Boender P, Oudshoorn P, Middeldorp J, Fipaldini C, La Monica N, et al. Significance of the immune response to a major, conformational B-cell epitope on the hepatitis C virus NS3 region defined by a human monoclonal antibody. J Virol 1994; 68:48294836. MEDLINE
  • 32
    Cerino A, Boender P, La Monica N, Rosa C, Habets W, Mondelli MU. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein. J Immunol 1993; 151:70057015. MEDLINE
  • 33
    Altuvia Y, Sette A, Sidney J, Southwood S, Margalit H. A structure based algorithm to predict potential binding peptides to MHC molecules with hydrophobic binding pockets. Hum Immunol 1997; 58(1):111. MEDLINE
  • 34
    Bertoletti A, Ferrari C, Penna A, Margolskee R, Schlicht HJ, Fowler P, Guilhot S, et al. HLA class I restricted cytotoxic T cells in acute viral hepatitis type B. Proc Natl Acad Sci U S A 1991; 88:1044510449. MEDLINE
  • 35
    Lechner F, Gruener NH, Urbani S, Uggeri J, Santantonio T, Kammer AR, Cerny A, et al. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 2000; 30:24792487. MEDLINE
  • 36
    He XS, Rehermann B, Lopez-Labrador FX, Boisvert J, Cheung R, Mumm J, Wedemeyer H, et al. Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A 1999; 96:56925697. MEDLINE
  • 37
    Rock KL, Goldberg AL. Degradation of cell proteins and generation of MHC class I-presented peptides. Annu Rev Immunol 1999; 17:739779. MEDLINE
  • 38
    Cohard M, Liu Q, Perkus M, Gordon E, Brotman B, Prince AM. Hepatitis C virus–specific CTL responses in PBMC from chimpanzees with chronic hepatitis C: determination of CTL and CTL precursor frequencies using a recombinant canarypox virus (ALVAC). J Immunol Methods 1998;121129.
  • 39
    Mandl S, Sigal LJ, Rock KL, Andino R. Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen. Proc Natl Sci U S A 1998; 95:82168221.
  • 40
    Brossart P, Goldrath AW, Butz EA, Martin S, Bevan MJ. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J Immunol 1997; 158:32723276.
  • 41
    Bettinotti MP, Kim CJ, Lee KH, Roden M, Cormier JN, Panelli M, Parker KK, et al. Stringent allele/epitope requirements for MART-1/Melan A immunodominance: implications for peptide-based immunotherapy. J Immunol 1998; 161:877889. MEDLINE
  • 42
    Butterfield LH, Jiliani SM, Chakraborty NG, Bui LA, Ribas A, Dissette VB, Lau R, et al. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. J Immunol 1998; 161:56075613. MEDLINE
  • 43
    Wong DKH, Dudley DD, Dohrenwend PB, Lauer GM, Chung RT, Thomas D, Walker BD. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. J Virol 2001; 75:12291235. MEDLINE
  • 44
    Bertoletti A, Chisari FV, Penna A, Guilhot S, Galati L, Missale G, Fowler P, et al. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol 1993; 67:23762380. MEDLINE
  • 45
    Yewdell JW, Bennik JR. Immunodominance in major histocompatibility complex class–I restricted T lymphocyte responses. Annu Rev Immunol 1999; 17:5189. MEDLINE
  • 46
    Wenthworth PA, Sette A, Celis E, Sidney J, Southwood S, Crimi C, Stitely S, et al. Identification of A2-restricted hepatitis C virus–specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. Int Immunol 1996; 8:651659. MEDLINE